News Medical on MSN

McMaster discovery could lead to new treatments for drug-resistant fungal infections

Dr. Gerry Wright's lab has identified a molecule that could revive an entire class of antifungal drugs and help combat ...
AOL

The threat of fungal infections is growing. Why is it so hard to make new drugs?

Last summer, the Food and Drug Administration denied an application for a new antifungal drug called olorofim, sending it back to the company with a request for more data. If approved, it would have ...

Basilea and Prokaryotics enter collaboration to develop a novel broad-spectrum antifungal for the treatment of severe invasive infections

Allschwil, Switzerland, January 07, 2026 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed ...
EuropaWire

Basilea Expands Anti-Infective Pipeline Through Antifungal Collaboration with Prokaryotics

Basilea Pharmaceutica has entered into a strategic collaboration with Prokaryotics to develop a first-in-class broad-spectrum antifungal therapy targeting severe invasive fungal infections. The ...
Phys.org

Research reveals how the superfungus Candida auris withstands antifungal treatment

A groundbreaking study from Michigan State University (MSU), published in Nature Communications, reveals how the multidrug-resistant superfungus Candida auris uniquely reconstructs its cell wall to ...